Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing
Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
The overall objective of the study is to determine the efficacy of corticosteroids in
preventing recurrent wheezing and asthma in high-risk, first-time severe wheezing children
with rhinovirus infection.
The secondary objectives are to determine duration and severity of each acute episode with
acute expiratory breathing difficulty, the number of episodes with acute expiratory breathing
difficulty, degree of pulmonary hyperreactivity and quality of life within 24 months after
study entry.
Phase:
Phase 4
Details
Lead Sponsor:
St. Olavs Hospital
Collaborators:
Haukeland University Hospital Helse Stavanger HF Karolinska University Hospital Turku University Hospital Ullevaal University Hospital University Hospital of North Norway University Hospital, Akershus